Aerpio Pharmaceuticals, Inc. Employment Agreements
15 Contracts & Agreements
- Executive Employment Agreement, dated August 15, 2022, by and between the Company and Bryan E. Ball (Filed With SEC on August 7, 2024)
- Executive Employment Agreement, dated September 29, 2023, by and between David J. Lennon and Aadi Bioscience, Inc (Filed With SEC on October 2, 2023)
- Executive Employment Agreement, dated October 28, 2021, by and between Aadi Bioscience, Inc. and Scott Giacobello (Filed With SEC on March 17, 2022)
- Employment Agreement dated October 19, 2021, by and between Loretta Itri and Aadi Bioscience, Inc (Filed With SEC on November 10, 2021)
- Employment Agreement dated September 14, 2021, by and between Brendan Delaney and the Company (Filed With SEC on September 20, 2021)
- Amended and Restated Employment Agreement, dated August 26, 2021, by and between Aadi Bioscience, Inc. and Neil Desai, Ph.D (Filed With SEC on August 27, 2021)
- Amendment No. 2 to Employment Agreement, entered into on January 31, 2021, by and between Aerpio Pharmaceuticals, Inc. and Joseph Gardner (Filed With SEC on February 1, 2021)
- Employment Agreement, dated November 6, 2019, by and between the Company and Regina Marek (Filed With SEC on November 7, 2019)
- Employment Agreement, effective as of November 15, 2017, by and between Aerpio Pharmaceuticals, Inc. and Michael Rogers (Filed With SEC on November 14, 2017)
- First Amendment to Employment Agreement, dated October 8, 2017, by and between Aerpio Pharmaceuticals, Inc. and Joseph Gardner (Filed With SEC on October 10, 2017)
- Employment Agreement, entered into on October 8, 2017, by and between Aerpio Pharmaceuticals, Inc. and Stephen Hoffman (Filed With SEC on October 10, 2017)
- AERPIO PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on April 14, 2017)
- AERPIO PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on April 14, 2017)
- AERPIO PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on April 14, 2017)
- AERPIO PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on March 17, 2017)